Baqsimi™ (glucagon) nasal powder

3mg

This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

BAQSIMI™ (glucagon) nasal powder: Indication

Baqsimi (glucagon nasal powder) is indicated for the treatment of severe hypoglycemia in patients with diabetes ages 4 and above.

Detailed Information

Baqsimi is an antihypoglycemic agent indicated for the treatment of severe hypoglycemia in patients with diabetes ages 4 and above.1

The safety and effectiveness of Baqsimi have not been established in pediatric patients younger than 4 years of age.1

Enclosed Prescribing Information

BAQSIMI™ (glucagon) nasal powder, for intranasal use, Lilly

Reference

1. Baqsimi [package insert]. Indianapolis, IN: Eli Lilly and Company; 2019.

Glossary

Baqsimi = Baqsimi™ (glucagon) nasal powder

Date of Last Review: July 24, 2019

Contact Lilly

Call Us

If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.

Available Mon - Fri, 8am - 7pm ET

Or you can

Ask us a question Chat with us

Submit a Request

Visit Us @LillyMedical